20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      mRNA structure regulates protein expression through changes in functional half-life

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          Despite widespread recognition that RNA is inherently structured, the interplay between local and global mRNA secondary structure (particularly in the coding region) and overall protein expression has not been thoroughly explored. Our work uses 2 approaches to disentangle the regulatory roles of mRNA primary sequence and secondary structure: global substitution with modified nucleotides and computational sequence design. By fitting detailed kinetic expression data to mathematical models, we show that secondary structure can increase mRNA half-life independent of codon usage. These findings have significant implications for both translational regulation of endogenous mRNAs and the emerging field of mRNA therapeutics.

          Abstract

          Messenger RNAs (mRNAs) encode information in both their primary sequence and their higher order structure. The independent contributions of factors like codon usage and secondary structure to regulating protein expression are difficult to establish as they are often highly correlated in endogenous sequences. Here, we used 2 approaches, global inclusion of modified nucleotides and rational sequence design of exogenously delivered constructs, to understand the role of mRNA secondary structure independent from codon usage. Unexpectedly, highly expressed mRNAs contained a highly structured coding sequence (CDS). Modified nucleotides that stabilize mRNA secondary structure enabled high expression across a wide variety of primary sequences. Using a set of eGFP mRNAs with independently altered codon usage and CDS structure, we find that the structure of the CDS regulates protein expression through changes in functional mRNA half-life (i.e., mRNA being actively translated). This work highlights an underappreciated role of mRNA secondary structure in the regulation of mRNA stability.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          Architecture and Secondary Structure of an Entire HIV-1 RNA Genome

          Single-stranded RNA viruses encompass broad classes of infectious agents and cause the common cold, cancer, AIDS, and other serious health threats. Viral replication is regulated at many levels, including using conserved genomic RNA structures. Most potential regulatory elements within viral RNA genomes are uncharacterized. Here we report the structure of an entire HIV-1 genome at single nucleotide resolution using SHAPE, a high-throughput RNA analysis technology. The genome encodes protein structure at two levels. In addition to the correspondence between RNA and protein primary sequences, a correlation exists between high levels of RNA structure and sequences that encode inter-domain loops in HIV proteins. This correlation suggests RNA structure modulates ribosome elongation to promote native protein folding. Some simple genome elements previously shown to be important, including the ribosomal gag-pol frameshift stem-loop, are components of larger RNA motifs. We also identify organizational principles for unstructured RNA regions. Highly used splice acceptors lie in unstructured motifs and hypervariable regions are sequestered from flanking genome regions by stable insulator helices. These results emphasize that the HIV-1 genome and, potentially, many coding RNAs are punctuated by numerous previously unrecognized regulatory motifs and that extensive RNA structure may constitute an additional level of the genetic code.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Thermodynamic parameters for an expanded nearest-neighbor model for formation of RNA duplexes with Watson-Crick base pairs.

            Improved thermodynamic parameters for prediction of RNA duplex formation are derived from optical melting studies of 90 oligoribonucleotide duplexes containing only Watson-Crick base pairs. To test end or base composition effects, new sets of duplexes are included that have identical nearest neighbors, but different base compositions and therefore different ends. Duplexes with terminal GC pairs are more stable than duplexes with the same nearest neighbors but terminal AU pairs. Penalizing terminal AU base pairs by 0.45 kcal/mol relative to terminal GC base pairs significantly improves predictions of DeltaG degrees37 from a nearest-neighbor model. A physical model is suggested in which the differential treatment of AU and GC ends accounts for the dependence of the total number of Watson-Crick hydrogen bonds on the base composition of a duplex. On average, the new parameters predict DeltaG degrees37, DeltaH degrees, DeltaS degrees, and TM within 3.2%, 6.0%, 6.8%, and 1.3 degreesC, respectively. These predictions are within the limit of the model, based on experimental results for duplexes predicted to have identical thermodynamic parameters.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates

              The success of mRNA-based therapies depends on the availability of a safe and efficient delivery vehicle. Lipid nanoparticles have been identified as a viable option. However, there are concerns whether an acceptable tolerability profile for chronic dosing can be achieved. The efficiency and tolerability of lipid nanoparticles has been attributed to the amino lipid. Therefore, we developed a new series of amino lipids that address this concern. Clear structure-activity relationships were developed that resulted in a new amino lipid that affords efficient mRNA delivery in rodent and primate models with optimal pharmacokinetics. A 1-month toxicology evaluation in rat and non-human primate demonstrated no adverse events with the new lipid nanoparticle system. Mechanistic studies demonstrate that the improved efficiency can be attributed to increased endosomal escape. This effort has resulted in the first example of the ability to safely repeat dose mRNA-containing lipid nanoparticles in non-human primate at therapeutically relevant levels. Sabnis et al. describe a novel amino lipid series for lipid nanoparticle-mediated delivery of mRNA. Enhanced delivery efficiency attributed to increased endosomal escape is demonstrated. An improved tolerability profile enables the first example of safe repeat dosing of mRNA containing lipid nanoparticles in non-human primate at therapeutically relevant levels.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc. Natl. Acad. Sci. U.S.A
                pnas
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                26 November 2019
                11 November 2019
                11 November 2019
                : 116
                : 48
                : 24075-24083
                Affiliations
                [1] aPlatform Research, Moderna, Inc., Cambridge, MA 02139
                Author notes
                5To whom correspondence may be addressed. Email: melissa.moore@ 123456modernatx.com .

                Edited by Joseph D. Puglisi, Stanford University School of Medicine, Stanford, CA, and approved October 8, 2019 (received for review May 9, 2019)

                Author contributions: D.M.M., B.J.C., V.P., K.L., J.R., M.J.M., and I.J.M. designed research; D.M.M., B.J.C., V.P., S.V.S., D.W.R., B.G., and N.K. performed research; V.P., S.V.S., B.G., K.L., and N.K. contributed new reagents/analytic tools; D.M.M., B.J.C., V.P., S.V.S., D.W.R., B.G., and N.K. analyzed data; and D.M.M., B.J.C., V.P., M.J.M., and I.J.M. wrote the paper.

                1Present address: Venture Labs, Flagship Pioneering, Cambridge, MA 02142.

                2Present address: Department of Cell and Molecular Biology, Korro Bio, Cambridge, MA 02139.

                3Present address: Microbiology and Immunology Department, Dartmouth College, Hanover, NH 03756.

                4Present address: Data Sciences, Genomics, and Bioinformatics Department, Alexion Pharmaceuticals, Boston, MA 02210.

                6Present address: Computational Sciences Department, LifeMine Therapeutics, Cambridge, MA 02140.

                Article
                201908052
                10.1073/pnas.1908052116
                6883848
                31712433
                d031ea67-69c6-40cb-a1e4-0a71d5fc33d1
                Copyright © 2019 the Author(s). Published by PNAS.

                This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY).

                History
                Page count
                Pages: 9
                Categories
                PNAS Plus
                Biological Sciences
                Biophysics and Computational Biology
                PNAS Plus

                mrna therapuetics,modified nucleotides,translation,rna structure,shape

                Comments

                Comment on this article